{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:29:45Z","timestamp":1792794585879,"version":"4.5.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100004141","name":"SGR","doi-asserted-by":"publisher","award":["01324"],"award-info":[{"award-number":["01324"]}],"id":[{"id":"10.13039\/100004141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004141","name":"SGR","doi-asserted-by":"publisher","award":["Q5856414G"],"award-info":[{"award-number":["Q5856414G"]}],"id":[{"id":"10.13039\/100004141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"AGAUR","doi-asserted-by":"publisher","award":["PI24\/01776"],"award-info":[{"award-number":["PI24\/01776"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"AGAUR","doi-asserted-by":"publisher","award":["ICI21\/00103"],"award-info":[{"award-number":["ICI21\/00103"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Institut de Salut Carlos III"},{"name":"European Union\u2014Next GenerationEU","id":[{"id":"https:\/\/ror.org\/019w4f821","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Ministerio de Sanidad y Consumo"},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RH042953"],"award-info":[{"award-number":["RH042953"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We aim to describe the epidemiology and risk factors for invasive fungal infections (IFI) and invasive mould infections (IMI) in hospitalized hematologic patients within the context of current hematologic therapies. Retrospective observational cohort study conducted on consecutive hematologic patients admitted to a tertiary hospital (2020\u20132023). Two populations were analysed: the full cohort of hospitalized patients (FC) and the subset of patients for whom mycological testing was specifically requested to rule out an IFI (SC). Proven or probable IFI was classified using European Organization for Research and Treatment of Cancer criteria. Risk factors for IFI and IMI were identified. A total of 1975 patients were included in the FC, whereas 1154 were included in the SC. IFI was diagnosed in 64 patients (65 episodes), and IMI in 43 patients (44 episodes). Aspergillosis was the most common IFI (58.4%), followed by candidemia (18.5%), Pneumocystis jirovecii pneumonia (PJP) (15.4%), mucormycosis (6.2%), and fusariosis (4.6%). Independent risk factors for IFI in the FC included acute leukemia (aOR 2.40, 95% CI 1.37\u20134.10, P\u00a0=\u00a0.002), corticosteroid use (aOR 2.36, 95% CI 1.40\u20134.03, P\u00a0=\u00a0.001) and graft versus host disease (GVHD) (aOR 2.13, 95% CI 0.93\u20134.46, P\u00a0=\u00a0.05). For IMI, risk factors were acute leukemia (aOR 2.71, 95% CI 1.33\u20135.52, P\u00a0=\u00a0.006), corticosteroid use (aOR 1.96, 95% CI 0.98\u20134.03, P\u00a0=\u00a0.05) and chronic lung disease (aOR 2.25, 95% CI 1.06\u20134.5, P\u00a0=\u00a0.02). In the SC, corticosteroid use (aOR 2.45, 95% CI 1.44\u20134.25, P\u00a0=\u00a0.001) was the independent risk factor for IFI, and corticosteroid use (aOR 2.40, 95% CI 1.21\u20134.91, P\u00a0=\u00a0.01) and GVHD (aOR 2.95, 95% CI 1.23\u20136.52, P\u00a0=\u00a0.009) were independent factors associated with IMI. Mortality was significantly higher in IFI patients compared to non-IFI patients (51.6% vs. 20.3%, P\u00a0&amp;lt;\u00a0.001). In this new era of haematology, the epidemiology of IFI is shifting, with Pneumocystis, Mucorales, and Fusarium becoming more prevalent. While corticosteroids and GVHD remain key risk factors, factors such as chronic lung disease are increasing its importance. Prolonged neutropenia may have decreased in relevance, likely due to prophylaxis. Preventing PJP has become a new challenge in IFI management.<\/jats:p>","DOI":"10.1093\/mmy\/myaf070","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T11:43:47Z","timestamp":1753357427000},"source":"Crossref","is-referenced-by-count":6,"title":["Epidemiological shifts of invasive fungal infections in the current era of haematology"],"prefix":"10.1093","volume":"63","author":[{"given":"Patricia","family":"Monzo-Gallo","sequence":"first","affiliation":[{"name":"Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona Department of Infectious Diseases, , 08036 Barcelona ,","place":["Spain"]},{"name":"Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona (UB) , c. Casanova, 143, 08036 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Teijon-Lumbreras","sequence":"additional","affiliation":[{"name":"Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona Department of Infectious Diseases, , 08036 Barcelona ,","place":["Spain"]},{"name":"Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona (UB) , c. Casanova, 143, 08036 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso Francesco","family":"Aiello","sequence":"additional","affiliation":[{"name":"Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona Department of Infectious Diseases, , 08036 Barcelona ,","place":["Spain"]},{"name":"Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona (UB) , c. Casanova, 143, 08036 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1517-4073","authenticated-orcid":false,"given":"Antonio","family":"Gallardo-Pizarro","sequence":"additional","affiliation":[{"name":"Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona Department of Infectious Diseases, , 08036 Barcelona ,","place":["Spain"]},{"name":"Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona (UB) , c. Casanova, 143, 08036 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Martinez-Urrea","sequence":"additional","affiliation":[{"name":"Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona Department of Infectious Diseases, , 08036 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Chumbita","sequence":"additional","affiliation":[{"name":"Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona Department of Infectious Diseases, , 08036 Barcelona ,","place":["Spain"]},{"name":"Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona (UB) , c. Casanova, 143, 08036 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Gras","sequence":"additional","affiliation":[{"name":"Institut Pierre Louis d\u2019\u00c9pid\u00e9miologie et de Sant\u00e9 Publique, INSERM, Sorbonne University , 75013 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Peyrony","sequence":"additional","affiliation":[{"name":"H\u00f4pital Saint Louis, Assistance Publique-H\u00f4pitaux Emergency Department, , 75010 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bodro","sequence":"additional","affiliation":[{"name":"Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona Department of Infectious Diseases, , 08036 Barcelona ,","place":["Spain"]},{"name":"Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona (UB) , c. Casanova, 143, 08036 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Magnano","sequence":"additional","affiliation":[{"name":"Hospital Clinic of Barcelona Department of Haematology, , 08036 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Herrera","sequence":"additional","affiliation":[{"name":"Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona Department of Infectious Diseases, , 08036 Barcelona ,","place":["Spain"]},{"name":"Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona (UB) , c. Casanova, 143, 08036 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Suarez-Lled\u00f3","sequence":"additional","affiliation":[{"name":"Hospital Clinic of Barcelona Department of Haematology, , 08036 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateu","family":"Espasa","sequence":"additional","affiliation":[{"name":"Hospital Clinic of Barcelona Department of Microbiology, , 08036 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1863-6379","authenticated-orcid":false,"given":"Francesc","family":"Marco","sequence":"additional","affiliation":[{"name":"Hospital Clinic of Barcelona Department of Microbiology, , 08036 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9374-0811","authenticated-orcid":false,"given":"Alex","family":"Soriano","sequence":"additional","affiliation":[{"name":"Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona Department of Infectious Diseases, , 08036 Barcelona ,","place":["Spain"]},{"name":"Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona (UB) , c. Casanova, 143, 08036 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8915-0683","authenticated-orcid":false,"given":"Carolina","family":"Garcia-Vidal","sequence":"additional","affiliation":[{"name":"Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona Department of Infectious Diseases, , 08036 Barcelona ,","place":["Spain"]},{"name":"Facultat de Medicina i Ci\u00e8ncies de la Salut, Universitat de Barcelona (UB) , c. Casanova, 143, 08036 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"2025082703512206600_bib1","doi-asserted-by":"crossref","first-page":"e00074","DOI":"10.1128\/cmr.00074-23","article-title":"Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease","volume":"37","author":"Hoenigl","year":"2024","journal-title":"Clin Microbiol Rev"},{"key":"2025082703512206600_bib2","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.3324\/haematol.2016.151837","article-title":"Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study","volume":"102","author":"Tisi","year":"2017","journal-title":"Haematologica"},{"key":"2025082703512206600_bib3","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.cmi.2024.02.023","article-title":"Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: A national retrospective study","volume":"30","author":"Jourdes","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"2025082703512206600_bib4","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"GJ","year":"1992","journal-title":"N Engl J Med"},{"key":"2025082703512206600_bib5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"A","year":"2007","journal-title":"N Engl J Med"},{"key":"2025082703512206600_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12281-023-00459-z","article-title":"Invasive aspergillosis and the Impact of azole-resistance","volume":"17","author":"Bosetti","year":"2023","journal-title":"Curr Fung Infect Rep"},{"key":"2025082703512206600_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jinf.2023.05.005","article-title":"Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study","volume":"87","author":"Puerta-Alcalde","year":"2023","journal-title":"J Infect"},{"key":"2025082703512206600_bib8","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s15010-024-02236-7","article-title":"Report of three azole-resistant Aspergillus fumigatus cases with TR34\/L98H mutation in hematological patients in Barcelona, Spain","volume":"52","author":"Monzo-Gallo","year":"2024","journal-title":"Infection"},{"key":"2025082703512206600_bib9","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the mycoses study group education and research consortium","volume":"71","author":"Peter\u00a0Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025082703512206600_bib10","volume-title":"BD BBLTM StackerTM Plates","author":"BD Diagnostics"},{"key":"2025082703512206600_bib11","volume-title":"BacT\/ALERT\u00ae Microbial Detection System","author":"bioM\u00e9rieux SA"},{"key":"2025082703512206600_bib12","volume-title":"BACTECTM 9240 Blood Culture System","author":"Becton, Dickinson and Company"},{"key":"2025082703512206600_bib13","volume-title":"CHROMagarTM Candida","author":"bioM\u00e9rieux SA"},{"key":"2025082703512206600_bib14","article-title":"M38 A reference method for broth dilution antifungal susceptibility testing of yeasts","author":"CLSI","year":"2017"},{"key":"2025082703512206600_bib15","volume-title":"YeastOne Sensititre","author":"TREK Diagnostic Systems"},{"key":"2025082703512206600_bib16","volume-title":"Etest","author":"bioM\u00e9rieux SA"},{"key":"2025082703512206600_bib17","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1093\/clinids\/19.Supplement_1.S8","article-title":"Epidemiology and control of fungal infections","volume":"19","author":"Pfaller","year":"1994","journal-title":"Clin Infect Dis"},{"key":"2025082703512206600_bib18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1086\/432060","article-title":"Emerging fungal diseases","volume":"41","author":"Nucci","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2025082703512206600_bib19","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1093\/mmy\/myx101","article-title":"Challenges in the diagnosis and treatment of mucormycosis","volume":"56","author":"Skiada","year":"2018","journal-title":"Med Mycol"},{"key":"2025082703512206600_bib20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/myc.13038","article-title":"Characteristics and risk factors for mortality of invasive non-Aspergillus mould infections in patients with haematologic diseases: A single-centre","volume":"63","author":"Lee","year":"2019","journal-title":"Mycoses"},{"key":"2025082703512206600_bib21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/ajhp\/zxad210","article-title":"Infectious complications among patients receiving ibrutinib for the treatment of hematological malignancies","volume":"81","author":"Tham","year":"2024","journal-title":"Am J Health Syst Pharm"},{"key":"2025082703512206600_bib22","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.amjms.2020.12.009","article-title":"Pulmonary aspergillosis: Spectrum of disease","volume":"361","author":"Moldoveanu","year":"2021","journal-title":"Am J Med Sci"},{"key":"2025082703512206600_bib23","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025082703512206600_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.riam.2014.09.001","article-title":"Inmunopatolog\u00eda de las micosis invasivas por hongos filamentosos","volume":"31","author":"Garc\u00eda-Vidal","year":"2014","journal-title":"Rev Iberoam Micol"},{"key":"2025082703512206600_bib25","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1080\/14787210.2022.2128762","article-title":"Risk of infection in patients with hematological malignancies receiving CAR T-cell therapy: Systematic review and meta-analysis","volume":"20","author":"Telli\u00a0Dizman","year":"2022","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2025082703512206600_bib26","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.cmi.2024.11.008","article-title":"Timeline and outcomes of viral and fungal infections after chimeric antigen receptor T-cell therapy: A large database analysis","volume":"31","author":"Sassine","year":"2025","journal-title":"Clin Microbiol Infect"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myaf070\/63854525\/myaf070.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/63\/8\/myaf070\/63854525\/myaf070.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/63\/8\/myaf070\/63854525\/myaf070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:51:30Z","timestamp":1756281090000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myaf070\/8213864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,5]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myaf070","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,7,26]]},"article-number":"myaf070"}}